In vitro interactions of licensed and novel antifungal drugs against Fusarium spp
Open Access
- 31 January 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 48 (1) , 69-71
- https://doi.org/10.1016/j.diagmicrobio.2003.09.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against ClinicalScedosporium prolificansIsolatesAntimicrobial Agents and Chemotherapy, 2003
- Efficacy of Liposomal Amphotericin B in Treatment of Systemic Murine FusariosisAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in HumansAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium sppAntimicrobial Agents and Chemotherapy, 2002
- Synergy, Pharmacodynamics, and Time-Sequenced Ultrastructural Changes of the Interaction between Nikkomycin Z and the Echinocandin FK463 against Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Antifungal Activities of the New Triazole UR-9825 against Clinically Important Filamentous FungiAntimicrobial Agents and Chemotherapy, 2001
- Investigational Antifungal AgentsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous FungiJournal of Clinical Microbiology, 2001
- Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for ManagementBlood, 1997
- Opportunistic fusarial infections in humansEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995